(Q43578599)

English

Determination of microsatellite instability, p53 and K-RAS mutations in hepatic metastases from patients with colorectal cancer: relationship with response to 5-fluorouracil and survival

scientific article published in May 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 November 2017

Determination of microsatellite instability, p53 and K-RAS mutations in hepatic metastases from patients with colorectal cancer: relationship with response to 5-fluorouracil and survival (English)

1 reference

Europe PubMed Central

24 November 2017

1 reference

based on heuristic

inferred from title

colorectal cancer

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Philippe Beaune

8

1 reference

Europe PubMed Central

24 November 2017

Pierre Laurent-Puig

9

1 reference

Europe PubMed Central

24 November 2017

author name string

C Rosty

1

1 reference

Europe PubMed Central

24 November 2017

M Chazal

2

1 reference

Europe PubMed Central

24 November 2017

M C Etienne

3

1 reference

Europe PubMed Central

24 November 2017

C Letoublon

4

1 reference

Europe PubMed Central

24 November 2017

A Bourgeon

5

1 reference

Europe PubMed Central

24 November 2017

J R Delpero

6

1 reference

Europe PubMed Central

24 November 2017

D Pezet

7

1 reference

Europe PubMed Central

24 November 2017

G Milano

10

1 reference

Europe PubMed Central

24 November 2017

language of work or name

0 references

publication date

1 May 2001

1 reference

Europe PubMed Central

24 November 2017

International Journal of Cancer

1 reference

Europe PubMed Central

24 November 2017

95

1 reference

Europe PubMed Central

24 November 2017

162-167

1 reference

Europe PubMed Central

24 November 2017

3

1 reference

Europe PubMed Central

24 November 2017

Survival for colon and rectal cancer in a population-based cancer registry

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

Metabolism and mechanism of action of 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

Biochemical pharmacology and analysis of fluoropyrimidines alone and in combination with modulators

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

Thymidylate synthase and drug resistance

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

A genetic model for colorectal tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

Disruption of p53 in human cancer cells alters the responses to therapeutic agents

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

Predicting response to cancer chemotherapy: the role of p53.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

Lessons from hereditary colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

Mismatch repair proficiency and in vitro response to 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellites.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

Evaluation of p53 protein expression as a marker for long-term prognosis in colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

p53 in colorectal cancer: clinicopathological correlation and prognostic significance

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

Analysis of the p53/BAX pathway in colorectal cancer: low BAX is a negative prognostic factor in patients with resected liver metastases

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

Irinotecan hydrochloride (CPT-11) resistance identified by K-ras mutation in patients with progressive colon cancer after treatment with 5-fluorouracil (5-FU).

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

Standardized approach for microsatellite instability detection in colorectal carcinomas.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

Better survival rates in patients with MLH1-associated hereditary colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

Chemotherapy for colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

Association of p53 mutations with short survival in colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

p53 and K-ras gene mutations correlate with tumor aggressiveness but are not of routine prognostic value in colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

Cancer therapy and p53.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

Gastric carcinomas with microsatellite instability: clinical features and mutations to the TGF-beta type II receptor, IGFII receptor, and BAX genes

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

K-ras andp53 mutations in hereditary non-polyposis colorectal cancers

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

The status of p53 in the metastatic progression of colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

p53 mutations in primary colorectal adenocarcinomas and liver metastases

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

Association of p53 gene and protein alterations with metastases in colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

p53 mutations as a possible predictor of response to chemotherapy in metastatic colorectal carcinomas

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

p53 status and the efficacy of cancer therapy in vivo

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010520%2995%3A3%3C162%3A%3AAID-IJC1028%3E3.0.CO%3B2-J

21 January 2018

Identifiers

10.1002/1097-0215(20010520)95:3<162::AID-IJC1028>3.0.CO;2-J

1 reference

Europe PubMed Central

24 November 2017

1 reference

Europe PubMed Central

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43578599&oldid=2101612020"